See the connections. Follow the source.
Review company and clinical-trial sources in a structured brief, with clear references and visible gaps.
Built for analysts following 5–10 U.S.-listed biotech companies
Navigate the evidence landscape
A company is more than one headline. Move between the sources that inform a research question, then inspect what the available evidence can establish.
ClinicalTrials.gov
Study identity, sponsor, phase and recruitment status help frame the next question. A registry status alone does not establish efficacy.
FDA / Original documents
Read the indication, population and warnings in the original label. The ALNY sample shows a historical label comparison with its unresolved questions.
SEC EDGAR / Company records
Filings provide reported financial and company context. Distinguish the reporting period, publication date and calculation assumptions before making comparisons.
PubMed / Original publications
Inspect the population, methods and limitations in the original publication. Source access and inclusion vary; the methodology explains the current research boundaries.
Build a research rhythm
If you already read trial records and company releases for 5–10 U.S.-listed biotech names, ORION gives that work a consistent home. Start with one company, inspect its sources, and return to the saved brief.
Research a biotech company or program. Open the underlying evidence and see what the available public record supports.
Open research ↗ 02 / FOLLOWKeep a short list of the companies you follow. Source-change monitoring is a separate Starter capability; current access and coverage are shown in the workspace.
Open your watchlist ↗ 03 / REVISITPin source facts to private research notes. Preserve the version you relied on and, with Starter, review changes to those exact fields.
Open research notebook ↗Inspect the difference
A summary should make the next check easier. ORION keeps public source links, evidence states, and limitations close to the research they support.
Illustrative trial record · Recruitment status field
What this does not establish: a recruitment status change alone does not tell you whether a treatment works.
Illustrative company disclosure · Expected timing field
Keep the distinction: a company's expected timeline is a forward-looking statement, not a confirmed result date.
Illustrative cross-source review · Unresolved timing
Keep the question open: check when each record was updated before treating a difference as a contradiction.
Your focused research workspace
Begin with Free on-demand research. Starter is the planned $29 monthly option for a focused coverage list, more research continuity, and eligible monitoring and export features.
One independent researcher. Monthly billing in USD. Actual feature availability, checkout status, and cancellation terms are shown on the pricing page before activation.
USD · Monthly plan
Free does not include ongoing change monitoring or exports. Paid activation depends on checkout availability.
Clarity is part of the product
Your confidence should come from the evidence you can inspect.
Follow the links and inspect the record. Coverage, source availability, and freshness can vary. Review current coverage.
Missing data and conflicting records remain part of the research. AI-generated summaries require verification against their original sources.
ORION is a facts-only research tool. It does not provide buy or sell recommendations, price targets, personalized investment advice, or trade execution.